Flatulence News and Research

RSS
Flatulence is the expulsion through the rectum of a mixture of gases that are byproducts of the digestion process of mammals and other animals.
Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

Avanir Pharmaceuticals, Wockhardt settle patent litigation related to NUEDEXTA capsules

Avanir Pharmaceuticals, Wockhardt settle patent litigation related to NUEDEXTA capsules

Avanir Pharmaceuticals enters into patent settlement agreement with Actavis

Avanir Pharmaceuticals enters into patent settlement agreement with Actavis

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

European authorisation of Aegerion Pharmaceuticals' Lojuxta brings hope for HoFH patients

European authorisation of Aegerion Pharmaceuticals' Lojuxta brings hope for HoFH patients

Does krill oil help your arthritis?

Does krill oil help your arthritis?

CHMP recommends approval of NUEDEXTA for treatment of pseudobulbar affect

CHMP recommends approval of NUEDEXTA for treatment of pseudobulbar affect

Hyperion Therapeutics receives FDA approval for Ravicti to treat urea cycle disorders

Hyperion Therapeutics receives FDA approval for Ravicti to treat urea cycle disorders

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Avanir initiates enrollment in AVP-923 Phase II clinical trial for treatment of agitation in AD patients

Avanir initiates enrollment in AVP-923 Phase II clinical trial for treatment of agitation in AD patients

FDA approves Ironwood’s LINZESS to treat irritable bowel syndrome with constipation

FDA approves Ironwood’s LINZESS to treat irritable bowel syndrome with constipation